CTRI/2024/01/060997尚未招募3 期
A prospective, pilot, interventional, single arm study to evaluate the insertion of intrauterine contraceptive device using the cross glide technology - NI
Department of Obstetrics and Gynaecology, PGIMER, Chandigarh0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Women desirous of long-term reversible contraception.
- •2.Patients who fulfil the WHO ‘Medical eligibility criteria for contraceptive use’
- •(Annexure I).
- •3.Patients who are willing to participate in the study.
排除标准
- •1. Women who are not willing to participate in the study.
- •2. Women with structural malformations of the uterus, cervix and vagina and presence
- •of fibroids.
- •3. Women with severe anaemia, uncontrolled diabetes, thrombocytopenia, any bleeding
- •4. Women with active genital tract infection/ pelvic inflammatory disease (PID).
- •5. Women with concurrent pregnancy.
- •6. Women with genital tract bleeding of unknown cause.
- •7. Women with prior history of ectopic pregnancy/ scarred uterus.
研究者
相似试验
招募中
不适用
A Clinical Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical MonoPointTM Reperfusion SystemTM for Aspiration Embolectomy in Acute Ischemic Stroke PatientsAcute Ischemic StrokeStroke - IschaemicNeurological - Other neurological disordersACTRN12619000890134Route 92 Medical, Inc.15
尚未招募
2 期
A clinical trial to study the effect and safety of the Siddha medicines in patients with Corona Virus diseaseCTRI/2020/07/026471The Directorate of Indian Medicine and Homoeopathy
招募中
4 期
A clinical trial to study the efficacy and safety of Ayurveda therapy protocol in the management of Covid-19 and its Post complicationsCTRI/2021/07/034937Pankajakasthuri herbal research foundation
尚未招募
Unknown
Evaluation of a Novel Continuous Glucose Monitoring System in Children and Adults with Type 1 and Type 2 DiabetesType 2 diabetesMetabolic and Endocrine - DiabetesType 1 diabetesACTRN12624000735550i-SENS, Inc.100
已完成
不适用
Evaluation of the efficacy and safety of a new Continuous Glucose Monitoring System in adult patients with type 1 and type 2 diabetesType 2 DiabetesType 1 DiabetesACTRN12622000290796i-SENS, Inc.69